Investigator

Alejandro Correa‐Paris

Cofounder · HIRU – Health Independent Research United

About

ACAlejandro Correa‐…
Papers(1)
Simple radiologic ass…
Collaborators(4)
Alicia Hernandez Guti…Antonio Gil-MorenoBerta Díaz-FeijooJuan Gilabert Estellés
Institutions(4)
Universitat Autnoma D…Hospital Universitari…Hospital Clínic de Ba…University of Valencia

Papers

Simple radiologic assessment of visceral obesity and prediction of surgical morbidity in endometrial cancer patients undergoing laparoscopic aortic lymphadenectomy: A reliability and accuracy study

AbstractAimTo evaluate the reliability of sagittal abdominal diameter (SAD)—a surrogate of visceral obesity—in magnetic resonance imaging, and its accuracy to predict the surgical morbidity of aortic lymphadenectomy.MethodsWe conducted a multicenter reliability (phase 1) and accuracy (phase 2) cohort study in three Spanish referral hospitals. We retrospectively analyzed data from the STELLA‐2 randomized controlled trial that included high‐risk endometrial cancer patients undergoing minimally invasive surgical staging. Patients were classified into subgroups: conventional versus robotic‐assisted laparoscopy, and transperitoneal versus extraperitoneal technique. In the first phase, we measured the agreement of three SAD measurements (at the umbilicus, renal vein, and inferior mesenteric artery) and selected the most reliable one. In phase 2, we evaluated the diagnostic accuracy of SAD to predict surgical morbidity. Surgical morbidity was the main outcome measure, it was defined by a core outcome set including variables related to blood loss, operative time, surgical complications, and para‐aortic lymphadenectomy difficulty.ResultsIn phase 1, all measurements showed good inter‐rater and intra‐rater agreement. Umbilical SAD (u‐SAD) was the most reliable one. In phase 2, we included 136 patients. u‐SAD had a good diagnostic accuracy to predict surgical morbidity in patients undergoing transperitoneal laparoscopic lymphadenectomy (0.73 in ROC curve). It performed better than body mass index and other anthropometric measurements. We calculated a cut‐off point of 246 mm (sensitivity: 0.56, specificity: 0.80).Conclusionsu‐SAD is a simple, reliable, and potentially useful measurement to predict surgical morbidity in endometrial cancer patients undergoing minimally invasive surgical staging, especially when facing transperitoneal aortic lymphadenectomy.

14Works
1Papers
4Collaborators

Positions

2019–

Cofounder

HIRU – Health Independent Research United

2020–

Facultativo Especialista de Area - Obstetricia y Ginecología

Servicio Navarro de Salud - Osasunbidea · Obstetricia y Ginecología - Hospital García Orcoyen (Estella)

2015–

Obstetrics & Gynecology specialist

Institut Catala De La Salut · ASSIR Esquerra (Atenció a la Salut Sexual i Reproductiva)

2015–

Obstetrics & Gynecology specialist

Hospital Quirón Barcelona · Equipo Cabero Riera GO

2011–

Resident

Hospital Vall d'Hebron · Obstetrics & Gynecology

2009–

Medico general

Profamilia

Education

2018

Ph.D.

Universitat Autònoma de Barcelona · Pediatria, Obstetricia y Ginecología

2015

Residente en Obstetricia y Ginecología

Hospital Vall d'Hebron

2009

Medico y Cirujano

Pontificia Universidad Javeriana

2003

Baccalauréat général (mention Assez-bien)

Lycée Français Louis Pasteur

Country

ES

Keywords
GynecologyHealth ResearchMinimally Invasive GynecologyWomen's Health